Strategic Financial Concepts, LLC Merck & Co., Inc. Transaction History

Strategic Financial Concepts, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$123.8 - $132.96 $4.06 Million - $4.37 Million	32,832 Added 1475.6%	35,057 $63.8 Million
Q1 2024 Apr 22, 2024	BUY	$113.24 - $131.95 $28,649 - $33,383	253 Added 12.83%	2,225 $294 Million
Q4 2023 Jan 18, 2024	SELL	$100.18 - $109.02 $60,408 - $65,739	-603 Reduced 23.42%	1,972 $215 Million
Q3 2023 Nov 07, 2023	BUY	$102.95 - $114.33 $16,266 - $18,064	158 Added 6.54%	2,575 $265 Million
Q2 2023 Sep 06, 2023	BUY	$108.61 - $118.38 $5,973 - $6,510	55 Added 2.33%	2,417 $279 Million
Q1 2023 Sep 06, 2023	BUY	$102.94 - $114.86 $243,144 - $271,299	2,362 New	2,362 $251 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Strategic Financial Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Financial Concepts, LLC with notifications on news.